Patent · US Expired

Optical isomers

US4981858A · kind A · utility

19Cited by
1References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 1989
Grant dateJan 1, 1991
Priority date
Expiry dateApr 18, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D497/20
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The (+)-cis-, (-)-cis-, (+)-trans- and (-)-trans- forms of 2-methylspiro(1,3-oxathiolan-5,3')quinuclidine are prepared by optical resolution of each of the (.+-.)-cis- and (.+-.)-trans-isomers. These compounds find application in treating diseases of the central nervous system in mammals, especially diseases due to a deficiency in the central cholinergic system. Biological tests indicate that the (-)-cis-form, as well as the (.+-.)-cis-isomer, shows particular promise for treating senile dementia of Alzheimer's type.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.